Hubei Goto Biopharm Co.,Ltd. (300966.SZ)
CNY 15.64
(0.51%)
CNY 15.64
(0.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 23 Million CNY | -42.78% |
| 2022 | 40.2 Million CNY | -48.67% |
| 2021 | 78.33 Million CNY | 46.99% |
| 2020 | 53.28 Million CNY | -27.0% |
| 2019 | 72.99 Million CNY | 3.28% |
| 2018 | 70.67 Million CNY | 48.99% |
| 2017 | 47.43 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -9.04 Million CNY | -4.36% |
| 2024 Q1 | 3.54 Million CNY | 1508.49% |
| 2024 Q2 | -8.66 Million CNY | -344.29% |
| 2023 FY | 23 Million CNY | -42.78% |
| 2023 Q3 | 5.31 Million CNY | -60.5% |
| 2023 Q4 | 220.53 Thousand CNY | -95.85% |
| 2023 Q1 | 4.02 Million CNY | 1388.93% |
| 2023 Q2 | 13.44 Million CNY | 234.15% |
| 2022 Q2 | 13.93 Million CNY | 6.84% |
| 2022 Q1 | 13.04 Million CNY | -46.24% |
| 2022 FY | 40.2 Million CNY | -48.67% |
| 2022 Q4 | 270.28 Thousand CNY | -97.91% |
| 2022 Q3 | 12.93 Million CNY | -7.17% |
| 2021 Q1 | 15.27 Million CNY | -30.55% |
| 2021 FY | 78.33 Million CNY | 46.99% |
| 2021 Q4 | 24.26 Million CNY | 86.35% |
| 2021 Q3 | 13.02 Million CNY | -49.46% |
| 2021 Q2 | 25.76 Million CNY | 68.66% |
| 2020 Q4 | 21.99 Million CNY | 74.47% |
| 2020 Q3 | 12.6 Million CNY | -39.63% |
| 2020 Q2 | 20.88 Million CNY | 1048.03% |
| 2020 Q1 | -2.2 Million CNY | -116.37% |
| 2020 FY | 53.28 Million CNY | -27.0% |
| 2019 Q4 | 13.46 Million CNY | 0.0% |
| 2019 FY | 72.99 Million CNY | 3.28% |
| 2018 FY | 70.67 Million CNY | 48.99% |
| 2017 FY | 47.43 Million CNY | 0.0% |